跳至主要内容
临床试验/JPRN-UMIN000017170
JPRN-UMIN000017170已完成未知

A multicenter pilot study of antithymocyte globulin in patients undergoing allogeneic peripheral blood stem cell transplantation - NJHSG-ATG

orth Japan Hematology Study Group (NJHSG)0 个研究点目标入组 6 人开始时间: 2015年4月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who are positive for HBs antigen or HIV antibody. 2. Patients with severe mental illness 3. Women who are pregnant, of childbearing potential, or lactating. 4. Patients with active other malignancies. 5. Patients with active infectious disease. 6. Patients who had a history of myocardial infarction, or who needed treatment for heart failure within 1 year. 7. Patients with cirrhosis 8. Obese patients (body mass index [BMI; 35 or greater]) 9. Patients with arrhythmia (CTCAE Grade 3 or more) 10. Patients who experienced serious hypersensitivity or anaphylaxis to antithymocyte globulin. 11. Patients who are not eligible for this study at the discretion of the investigator.

研究者

发起方
orth Japan Hematology Study Group (NJHSG)

相似试验

A multicenter pilot study of antithymocyte globulin... | 临床试验